GGrantIndex
← Leaderboards

Joslin Diabetes Center

Boston, MA

Compare ↔
$525,903,281
Total funding
313
Grants

Funding over time

peak $39.5M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$532,026,254 · 314

By mechanism

R01$314,350,716 · 125
P30$35,317,285 · 42
U01$34,169,369 · 10
UC4$33,488,112 · 2
R37$15,593,192 · 2
T32$14,129,350 · 2

Investigators at Joslin Diabetes Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Cristina Aguayo-Mazzucato$1,871,2462 gr2Aleksandar David Kostic$1,234,6631 gr3Hetal Shah$645,0021 gr4Dario F De Jesus$249,0001 gr5Jonathan Dreyfuss$42,7501 gr

Emerging Leaders

6–10 yrs in

1Sarah Lessard$3,867,4832 gr2Monika Anna Niewczas$3,376,4473 gr3Weikang Cai$1,940,5662 gr4Peng Yi$1,924,6291 gr5Farnaz Shamsi$1,243,3542 gr6Emrah Altindis$1,024,5901 gr7Fabricio Simao$431,2101 gr

All-Time

Most funded here, all years

1C Ronald Kahn$71,123,96214 gr2Diane J Mathis$38,245,46411 gr3Laurie J Goodyear$26,765,21610 gr4Andrzej S Krolewski$25,577,63910 gr5George L King$20,576,01613 gr6Alessandro Doria$19,840,0829 gr7Martin G Myers$19,602,3397 gr8Steven E Shoelson$18,436,25810 gr

Largest grants

PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D$24,312,202
UC4 · FY2013 · DK
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D$7,000,000
UC4 · FY2017 · DK
Use of Continuous Glucose Monitoring with Automated Clinical Decision Support to Reduce Hypoglycemia in Older Adults with Type 1 Diabetes$4,018,286
DP3 · FY2016 · DK
Validation of Potential Protective Factors from Diabetic Complications$3,963,638
DP3 · FY2011 · DK
Diabetes Genome Anatomy Project (DGAP)$3,500,001
R01 · FY2004 · DK
Diabetes Genome Anatomy Project (DGAP)$3,500,000
R01 · FY2005 · DK
ENHANCING CARBOHYDRATE QUALITY IN DIABETES TYPE - 1$3,450,064
N01 · FY2010 · HD
Diabetes Genome Anatomy Project (DGAP)$3,417,748
R01 · FY2006 · DK
Aging and Rejuvenation of the hematopoietic stem cell niche$2,424,125
DP2 · FY2008 · OD
Search for biomarkers to measure progression of diabetic nephropathy in Type 1 diabetes; application of proteomics technologies$2,340,294
DP3 · FY2016 · DK
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy$2,272,183
DP3 · FY2016 · DK
Diabetes and Endocrinology Research Center$2,174,347
P30 · FY2002 · DK
Epitranscriptomics in human obesity and type 2 diabetes$2,043,780
RC2 · FY2024 · DK
Diabetes Genome Anatomy Project (DGAP)$2,000,001
R01 · FY2003 · DK
Diabetes Genome Anatomy Project (DGAP)$2,000,000
R01 · FY2002 · DK
Epitranscriptomics in human obesity and type 2 diabetes$1,972,780
RC2 · FY2025 · DK
Interrogation of dynamic RNA modifications in beta cells in type 1 diabetes$1,925,910
UC4 · FY2017 · DK
Diabetes Research Center$1,919,986
P30 · FY2015 · DK
Diabetes Research Center$1,919,986
P30 · FY2014 · DK
Diabetes Research Center$1,919,986
P30 · FY2016 · DK